← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $169B	3,263	+457	+16%	$224B
2	2 Eli Lilly LLY $1.13T	2,304	+252	+12%	$219B
3	3 Amgen AMGN $235B	2,293	+159	+7%	$95.5B
4	4 Becton Dickinson BDX $52.1B	1,568	+93	+6%	$62.1B
5	5 McKesson MCK $117B	1,097	+129	+13%	$32.1B
6	6 Regeneron Pharmaceuticals REGN $81.8B	1,078	+59	+6%	$56.9B
7	7 AstraZeneca AZN $256B	950	+41	+5%	$29.4B
8	8 Novo Nordisk NVO $172B	885	+80	+10%	$14.7B
9	9 Conagra Brands CAG $6.83B	774	+54	+8%	$13.7B
10	10 West Pharmaceutical WST $26.9B	729	+59	+9%	$32.2B
11	11 ResMed RMD $33.6B	724	+37	+5%	$24.6B
12	12 DELISTED CATALENT, INC. CTLT	562	+33	+6%	$22.5B
13	13 Lamb Weston LW $7.37B	548	-11	-2%	$7.83B
14	14 DaVita DVA $12B	492	-19	-4%	$9.61B
15	15 Teva Pharmaceutical Industries Limited TEVA $48.2B	450	+21	+5%	$4.14B
16	ARNA 16 DELISTED Arena Pharmaceuticals Inc ARNA	317	+82	+35%	$4.87B
17	17 Medifast MED $135M	297	+1	+0.3%	$2.05B
18	18 Inspire Medical Systems INSP $2.01B	289	+36	+14%	$5.95B
19	19 Accendra Health ACH $18M	271	+24	+10%	$3.14B
20	20 Herbalife HLF $1.54B	245	+14	+6%	$4.16B
21	21 Opko Health OPK $1.19B	235	+29	+14%	$915M
22	22 DELISTED WW International WW	200	-5	-2%	$1.03B
23	TWNK 23 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	199	+14	+8%	$2.83B
24	24 MannKind Corp MNKD $977M	191	+10	+6%	$479M
25	25 Fresenius Medical Care FMS $11.8B	174	+14	+9%	$899M